HU204819B - Process for producing pharmaceutical compositions comprising 1h-imidazoles and 1h-1,2,4-triazoles as active ingredient and for producing the active ingredients - Google Patents
Process for producing pharmaceutical compositions comprising 1h-imidazoles and 1h-1,2,4-triazoles as active ingredient and for producing the active ingredients Download PDFInfo
- Publication number
- HU204819B HU204819B HU881508A HU150888A HU204819B HU 204819 B HU204819 B HU 204819B HU 881508 A HU881508 A HU 881508A HU 150888 A HU150888 A HU 150888A HU 204819 B HU204819 B HU 204819B
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- compounds
- phenyl
- parts
- triazol
- Prior art date
Links
- 0 CC1OCC(COCc2cc(N(CC3)CCN3c(cc3)ccc3N(C(*)=NN3*)C3=O)ccc2)OC1c(ccc(F)c1)c1F Chemical compound CC1OCC(COCc2cc(N(CC3)CCN3c(cc3)ccc3N(C(*)=NN3*)C3=O)ccc2)OC1c(ccc(F)c1)c1F 0.000 description 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Auxiliary Devices For And Details Of Packaging Control (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3020787A | 1987-03-25 | 1987-03-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUT50333A HUT50333A (en) | 1990-01-29 |
HU204819B true HU204819B (en) | 1992-02-28 |
Family
ID=21853062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU881508A HU204819B (en) | 1987-03-25 | 1988-03-24 | Process for producing pharmaceutical compositions comprising 1h-imidazoles and 1h-1,2,4-triazoles as active ingredient and for producing the active ingredients |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0283992B1 (sh) |
JP (1) | JPH0667929B2 (sh) |
KR (1) | KR960012370B1 (sh) |
CN (1) | CN1038588C (sh) |
AT (1) | ATE80626T1 (sh) |
AU (1) | AU600107B2 (sh) |
CA (1) | CA1313875C (sh) |
CY (1) | CY1837A (sh) |
DE (1) | DE3874576T2 (sh) |
DK (1) | DK168336B1 (sh) |
ES (1) | ES2044991T3 (sh) |
FI (1) | FI89798C (sh) |
GR (1) | GR3006420T3 (sh) |
HK (1) | HK50395A (sh) |
HU (1) | HU204819B (sh) |
IE (1) | IE61802B1 (sh) |
IL (1) | IL85823A (sh) |
MA (1) | MA21227A1 (sh) |
NO (1) | NO168476C (sh) |
NZ (1) | NZ223799A (sh) |
PH (1) | PH25023A (sh) |
PT (1) | PT87073B (sh) |
SU (1) | SU1635900A3 (sh) |
TN (1) | TNSN88025A1 (sh) |
ZA (1) | ZA882118B (sh) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1331757C (en) * | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
NZ233502A (en) * | 1989-06-09 | 1991-11-26 | Janssen Pharmaceutica Nv | 4-(1,2,4-triazole- or imidazole-phenyl-substituted) -1-(1,3-dioxolan-4-ylmethoxyphenyl) piperazine derivatives; preparatory processes: fungicidal and antiviral compositions |
US5075309A (en) * | 1989-06-09 | 1991-12-24 | Janssen Pharmaceutica N.V. | Antifungal 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]triazolones and imidazolones |
WO1993007847A1 (en) * | 1991-10-15 | 1993-04-29 | Kenneth Vincent Mason | Anti-seborrhoeic formulation |
IL103558A0 (en) * | 1991-10-30 | 1993-03-15 | Schering Corp | Tri-substituted tetrahydrofuran antifungals |
TW218017B (sh) * | 1992-04-28 | 1993-12-21 | Takeda Pharm Industry Co Ltd | |
PH30929A (en) * | 1992-09-03 | 1997-12-23 | Janssen Pharmaceutica Nv | Beads having a core coated with an antifungal and a polymer. |
CN1078210C (zh) * | 1994-01-24 | 2002-01-23 | 詹森药业有限公司 | 水溶性吡咯系杀真菌剂 |
WO1996013499A1 (en) * | 1994-10-27 | 1996-05-09 | Janssen Pharmaceutica N.V. | Apolipoprotein-b synthesis inhibitors |
US5625064A (en) * | 1995-04-19 | 1997-04-29 | Schering Corporation | Process for the preparation of triazolones |
TW457240B (en) * | 1995-04-20 | 2001-10-01 | Janssen Pharmaceutica Nv | Novel triazolones as apolipoprotein-B synthesis inhibitors |
US20030224006A1 (en) | 2002-03-01 | 2003-12-04 | Zaworotko Michael J. | Multiple-component solid phases containing at least one active pharmaceutical ingredient |
US7790905B2 (en) | 2002-02-15 | 2010-09-07 | Mcneil-Ppc, Inc. | Pharmaceutical propylene glycol solvate compositions |
WO2003101392A2 (en) | 2002-05-31 | 2003-12-11 | Transform Pharmaceuticals, Inc. | Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
US7446107B2 (en) | 2002-02-15 | 2008-11-04 | Transform Pharmaceuticals, Inc. | Crystalline forms of conazoles and methods of making and using the same |
US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
JP2006500377A (ja) | 2002-06-21 | 2006-01-05 | トランスフォーム・ファーマシューティカルズ・インコーポレイテッド | 改善された溶解性を有する医薬組成物 |
US8183290B2 (en) | 2002-12-30 | 2012-05-22 | Mcneil-Ppc, Inc. | Pharmaceutically acceptable propylene glycol solvate of naproxen |
WO2005118577A1 (en) * | 2004-04-22 | 2005-12-15 | Transform Pharmaceuticals, Inc. | Novel saperconazole crystalline forms and related processes, pharmaceutical compositions and methods |
CN102906087B (zh) * | 2010-05-19 | 2016-03-23 | 桑多斯股份公司 | 制备手性三唑酮的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4267179A (en) * | 1978-06-23 | 1981-05-12 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
US4619931A (en) * | 1983-02-28 | 1986-10-28 | Janssen Pharmaceutica, N.V. | [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles |
CA1292472C (en) * | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
-
1988
- 1988-03-08 NZ NZ223799A patent/NZ223799A/xx unknown
- 1988-03-16 CA CA000561609A patent/CA1313875C/en not_active Expired - Fee Related
- 1988-03-18 KR KR1019880002863A patent/KR960012370B1/ko not_active IP Right Cessation
- 1988-03-21 DE DE8888104473T patent/DE3874576T2/de not_active Expired - Fee Related
- 1988-03-21 ES ES88104473T patent/ES2044991T3/es not_active Expired - Lifetime
- 1988-03-21 AT AT88104473T patent/ATE80626T1/de not_active IP Right Cessation
- 1988-03-21 EP EP88104473A patent/EP0283992B1/en not_active Expired - Lifetime
- 1988-03-22 MA MA21468A patent/MA21227A1/fr unknown
- 1988-03-23 IL IL85823A patent/IL85823A/xx not_active IP Right Cessation
- 1988-03-24 AU AU13585/88A patent/AU600107B2/en not_active Ceased
- 1988-03-24 FI FI881404A patent/FI89798C/fi not_active IP Right Cessation
- 1988-03-24 NO NO881306A patent/NO168476C/no not_active IP Right Cessation
- 1988-03-24 IE IE89388A patent/IE61802B1/en not_active IP Right Cessation
- 1988-03-24 SU SU884356110A patent/SU1635900A3/ru active
- 1988-03-24 DK DK163288A patent/DK168336B1/da not_active IP Right Cessation
- 1988-03-24 PT PT87073A patent/PT87073B/pt not_active IP Right Cessation
- 1988-03-24 HU HU881508A patent/HU204819B/hu not_active IP Right Cessation
- 1988-03-24 ZA ZA882118A patent/ZA882118B/xx unknown
- 1988-03-25 JP JP63069915A patent/JPH0667929B2/ja not_active Expired - Fee Related
- 1988-03-25 PH PH36690A patent/PH25023A/en unknown
- 1988-03-25 CN CN88101660A patent/CN1038588C/zh not_active Expired - Fee Related
- 1988-03-25 TN TNTNSN88025A patent/TNSN88025A1/fr unknown
-
1992
- 1992-12-02 GR GR920402784T patent/GR3006420T3/el unknown
-
1995
- 1995-04-06 HK HK50395A patent/HK50395A/xx not_active IP Right Cessation
- 1995-12-01 CY CY183795A patent/CY1837A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU204819B (en) | Process for producing pharmaceutical compositions comprising 1h-imidazoles and 1h-1,2,4-triazoles as active ingredient and for producing the active ingredients | |
US4916134A (en) | 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones | |
JP2574656B2 (ja) | 置換(4−フエニル−1−ピペラジニル)フエノール誘導体及びその製造方法 | |
NO316173B1 (no) | Tetrahydrofuran-antifungale midler | |
JPS6353192B2 (sh) | ||
HU227281B1 (en) | Watersoluble azole antifungals, process for their preparation intermediates, and pharmaceutical compositions containing the compounds | |
HU177458B (en) | Process for preparing new 1-/1,3-dioxolan-2-yl-methyl/-1h-imidazole derivatives | |
KR100593395B1 (ko) | 광범위-스펙트럼 항진균제로서의 수용성 아졸 | |
FI96031C (fi) | Menetelmä terapeuttisesti aktiivisten 4-/4-/4-/4-/2-(2,4-difluorifenyyli)-2-(1H-atsolyylimetyyli)-1,3-dioksolan-4-yyli/metoksi/fenyyli/-1-piperatsinyyli/fenyylisubstituoitujen triatsolonien ja imidatsolonien valmistamiseksi | |
CZ328897A3 (cs) | Nové triazolony jako inhibitory syntézy apolipoproteinu-B | |
SU1069625A3 (ru) | Способ получени азолов или их кислотно-аддитивных солей их стереоизомеров | |
BG60430B2 (bg) | Хетероциклични производни на (4-фенилпиперазин-1-ил-арилокси- метил-1,3-диоксолан-2-ил)-метил-1н-имидазоли и 1н-1,2,4-триа- золи,методи за тяхното получаване и състави,които ги съдържат | |
HU184845B (en) | Process for producing 1-bracket-1,3-dioxol-2-nyl-methyl-bracket closed-1h-1,2,4-triazole derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HMM4 | Cancellation of final prot. due to non-payment of fee |